公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2020 | Weight gain and dyslipidemia among virally suppressed HIV-positive patients switching to co-formulated elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide | Kuo P.-H.; HSIN-YUN SUN ; YU-CHUNG CHUANG ; Wu P.-Y.; Liu W.-C.; CHIEN-CHING HUNG | International Journal of Infectious Diseases | 36 | 40 |